HSE to consider access to weight loss drug Mounjaro
A decision by a HSE expert group to approve the drug Mounjaro could be "transformative", according to Professor Donal O'Shea, a consultant endocrinologist and the HSE clinical lead in the National Obesity Programme.
Read original article on News Headlines →